Andrew Perry
CIK 1877793 · Chief Commercial Officer · last filed 2024-09-18
Andrew Perry is a Chief Commercial Officer who has filed 10 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for GTHX, was dated Sep 18, 2024. Across all open-market trades the lifetime net is −$55.4K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
10
-$55.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. (GTHX) Delisted | Chief Commercial Officer | 14,232 | $7.15 | $101.8K | -$55.4K | 10 | 2024-09-18 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-18 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | −112,614 | $0 | EDGAR |
| 2024-07-08 | G1 Therapeutics, Inc. (GTHX) Delisted | Sell (S) | −1,337 | -$3.4K | EDGAR |
| 2024-07-03 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +35,000 | $0 | EDGAR |
| 2024-05-15 | G1 Therapeutics, Inc. (GTHX) Delisted | Sell (S) | −8,151 | -$39.0K | EDGAR |
| 2024-01-08 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | +31,157 | -$7.5K | EDGAR |
| 2023-07-07 | G1 Therapeutics, Inc. (GTHX) Delisted | Sell (S) | −355 | -$871 | EDGAR |
| 2023-05-12 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +35,000 | $0 | EDGAR |
| 2023-01-05 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | +15,280 | -$4.6K | EDGAR |
| 2022-01-05 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2021-08-17 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | — | $0 | EDGAR |